Pulmonx Corp
- Last sale
- Nov 12, 2026 · +1.18%
- Market cap
- $130.87M
- 43.55M shares
- Filings
- 451
Q3 2026+8.0% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026−1.6% FY25 yoy
- $130.87M
- —
- 1.5×
- 3.8×
- -19.57%
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $90,497,000 | reported | |
| FY 2024 | 2024-12-31 | $83,789,000 | reported | |
| FY 2023 | 2023-12-31 | $68,675,000 | reported | |
| FY 2022 | 2022-12-31 | $53,662,000 | reported | |
| FY 2021 | 2021-12-31 | $48,416,000 | reported | |
| FY 2020 | 2020-12-31 | $32,733,000 | reported | |
| FY 2019 | 2019-12-31 | $32,595,000 | reported | |
| FY 2018 | 2018-12-31 | $20,004,000 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2023 | — | $0.00 | $0.00 | — | 38.54M sh | +2.4% | — |
| FY2022 | — | $27.00K | $27.00K | — | 37.65M sh | +1.7% | — |
| FY2021 | — | $26.00K | $26.00K | — | 37.02M sh | +3.7% | — |
| FY2020 | — | $21.00K | $21.00K | — | 35.69M sh | +1,599.4% | — |
| FY2019 | — | $12.00K | $12.00K | — | 2.10M sh | — | — |
Segments
Geography
LineFY2025ShareChange
United States$57.02M63%+1.0%
Europe, Middle-East and Africa (“EMEA”)$26.99M30%+20.9%
Asia Pacific$6.23M6.9%+40.3%
Other International$260.00K0.3%−53.2%
Total$90.50M
Surgical & medical instruments & apparatus
Pulmonx Corp is the 52nd largest of the 143 covered companies the SEC files under this code, by revenue. SIC 3841
CompanyRevenueGrowthNet marginMarket cap
BBNXBeta Bionics, Inc.$100.3M53.9%73.0%$897.6MNPCENeuroPace Inc$100.0M25.1%21.5%$425.9MKMTSKestra Medical Technologies, Ltd.$95.1M59.0%138.4%$1.7B
LUNGPulmonx Corp (this company)$90.5M8.0%59.7%$130.9M
DCTHDelcath Systems, Inc.$85.2M129.1%3.2%$743.1MIRMDIradimed Corp$83.8M14.4%26.8%$1.1BTELATELA Bio, Inc.$80.3M15.8%48.4%$38.0MPDEXPro DEX Inc$77.5M16.5%17.6%$225.5MSGHTSight Sciences, Inc.$77.4M3.1%49.7%$456.4MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Pulmonx Corp · CIK 1127537 · Engraved from SEC EDGAR